Cytomed Therapeutics Limited (GDTC) Stock Price, Quote & News

Company Profile

CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. Its lead product candidate is CTM-N2D, an expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor, which is in Phase I clinical trials comprising to improve anti-cancer cytotoxicity. The company is also developing iPSC-gdNKT, a plu...

Industry: Biotechnology

Sector: Healthcare

Phone: 65 6250 7738

Website: w2.cytomed.sg

Address:

1 Commonwealth Lane, No. 08-22, Singapore, Singapore

KingCornbread8853 Oct. 6 at 6:36 PM

$GDTC

0 · Reply

TheManWhoSoldTheWorld Oct. 2 at 3:32 PM

$GDTC https://www.globenewswire.com/news-release/2025/10/02/3160232/0/en/CytoMed-Therapeutics-Announces-Publication-of-Collaborative-Research-with-The-University-of-Texas-MD-Anderson-Cancer-Center-Demonstrating-the-Potential-of-Allogeneic-%CE%B3%CE%B4-T-Cells-in-.html

0 · Reply

NVDAMillionaire Sep. 29 at 12:45 PM

$GDTC Great piece that accurately captures GDTC's current position. So if you want to refresh your understanding of GDTC or learn about GDTC for the first time, this is essential reading. https://beyondspx.com/quote/GDTC/analysis/cytomed-therapeutics-pioneering-cell-therapy-innovation-and-strategic-expansion-nasdaq-gdtc

0 · Reply

stoneblood Sep. 12 at 6:25 PM

$GDTC trickle trickle

0 · Reply

KingCornbread8853 Sep. 10 at 7:07 PM

$GDTC

0 · Reply

JimBull Sep. 10 at 9:26 AM

Singapore stocks list 2 : $CUPR $JBDI $GDTC $GFAI

0 · Reply

stoneblood Aug. 25 at 2:41 PM

$GDTC sleeper play unusual volume uptick for the move back over $2 worth watching

0 · Reply

BaringsTrading Jul. 23 at 1:45 AM

$ABVX Next is $GDTC

0 · Reply

BaringsTrading Jul. 11 at 8:39 PM

$INKT $GDTC is next

0 · Reply

kshonstocks Jun. 18 at 5:15 PM

$GDTC turning on chart keep an eye on it

0 · Reply

CytoMed Therapeutics Limited (GDTC) Q2 2025 Earnings Call Prepared Remarks Transcript

Oct 2, 2025, 7:00 AM EDT - 9 days ago

CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, MD Anderson Cancer Center, Demonstrating the Potential of Allogeneic γδ T Cells in Acute Myeloid Leukemia

Aug 28, 2025, 9:00 AM EDT - 6 weeks ago

Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on its recent cord blood bank acquisition

Aug 18, 2025, 9:00 PM EDT - 7 weeks ago

CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program

Jul 21, 2025, 10:01 AM EDT - 2 months ago

Update On Clinical Trial Milestone - CytoMed Therapeutics Achieves Completion of Dose Level 1 of its ANGELICA TRIAL, and Proceeding to Dose Level 2 in Patients with Advanced Solid Tumors or Haematological Malignancies

Apr 28, 2025, 4:05 PM EDT - 5 months ago

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates

Feb 6, 2025, 7:20 AM EST - 8 months ago

CytoMed Therapeutics announces Chairman's Letter to the Company's shareholders

Jan 6, 2025, 11:10 AM EST - 9 months ago

Singapore-Based CytoMed Therapeutics Stock Dips After SunAct Joins Clinical Trial As Joint Sponsor

Aug 20, 2024, 7:00 AM EDT - 1 year ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD ELUT EUDA GOSS GOVX IMRN

Jul 17, 2024, 7:00 AM EDT - 1 year ago

CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers

Mar 20, 2024, 8:30 AM EDT - 1 year ago

CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration

Mar 18, 2024, 6:00 AM EDT - 1 year ago

CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies

Mar 4, 2024, 5:00 AM EST - 1 year ago

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

Jan 29, 2024, 7:00 AM EST - 1 year ago

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

Dec 5, 2023, 7:30 AM EST - 2 years ago

CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology

Nov 17, 2023, 9:21 AM EST - 2 years ago

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

Nov 14, 2023, 7:47 AM EST - 2 years ago

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Oct 24, 2023, 1:00 PM EDT - 2 years ago

CytoMed Therapeutics Adds to its Intellectual Portfolio After Securing Chinese Patent for its Licensed iPSC-Based Technology

Sep 25, 2023, 7:00 AM EDT - 2 years ago

Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology

Sep 1, 2023, 8:00 PM EDT - 2 years ago

CytoMed Therapeutics: An Innovative Immunology Biotech Company To Watch

Aug 29, 2023, 9:00 AM EDT - 2 years ago

CytoMed Expands Research Collaboration into China After Entering Into MOU

Aug 20, 2023, 3:50 AM EDT - 2 years ago

Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal

ARQT SMMT

Aug 17, 2023, 7:30 AM EDT - 2 years ago

CytoMed Therapeutics Limited to Present at the August 24th Virtual Investor Summit

Aug 15, 2023, 1:00 PM EDT - 2 years ago

CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γD T In Vivo Persistency

Aug 1, 2023, 7:00 AM EDT - 2 years ago

Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

Jul 27, 2023, 9:00 AM EDT - 2 years ago

CytoMed Therapeutics Announces U.S. Patent Granted For its Licensed, Novel CAR-Gamma Delta T Cell Technology

Jul 6, 2023, 7:00 AM EDT - 2 years ago

A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the US

May 11, 2023, 9:00 AM EDT - 2 years ago

CytoMed Therapeutics to Ring Nasdaq Closing Bell

May 9, 2023, 10:07 AM EDT - 2 years ago

CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-the-Shelf Gamma Delta T Cells in Oncology

Apr 13, 2023, 8:00 PM EDT - 2 years ago

CytoMed Therapeutics Limited Announces Pricing of Initial Public Offering

Apr 7, 2023, 5:30 AM EDT - 2 years ago

U.S. IPO Weekly Recap: Small Deals Drive Activity In The IPO Market's Short Week

ARBB ATMU GDHG GMM ISPR KVUE MGIH

Feb 3, 2023, 5:46 PM EST - 2 years ago

IPO Update: CytoMed Therapeutics Aims For $11 Million U.S. IPO

KingCornbread8853 Oct. 6 at 6:36 PM

$GDTC

0 · Reply

TheManWhoSoldTheWorld Oct. 2 at 3:32 PM

0 · Reply

NVDAMillionaire Sep. 29 at 12:45 PM

0 · Reply

stoneblood Sep. 12 at 6:25 PM

$GDTC trickle trickle

0 · Reply

KingCornbread8853 Sep. 10 at 7:07 PM

$GDTC

0 · Reply

JimBull Sep. 10 at 9:26 AM

Singapore stocks list 2 : $CUPR $JBDI $GDTC $GFAI

0 · Reply

stoneblood Aug. 25 at 2:41 PM

$GDTC sleeper play unusual volume uptick for the move back over $2 worth watching

0 · Reply

BaringsTrading Jul. 23 at 1:45 AM

$ABVX Next is $GDTC

0 · Reply

BaringsTrading Jul. 11 at 8:39 PM

$INKT $GDTC is next

0 · Reply

kshonstocks Jun. 18 at 5:15 PM

$GDTC turning on chart keep an eye on it

0 · Reply

topstockalerts Apr. 10 at 1:26 PM

$GDTC premarket move..

0 · Reply

topstockalerts Apr. 10 at 11:25 AM

Pre Market Top Gainers PT2 $HYFM $HLP $GNFT $ATXS $GDTC

0 · Reply

KingCornbread8853 Mar. 31 at 4:22 PM

$GDTC

0 · Reply

KingCornbread8853 Feb. 21 at 5:07 PM

$GDTC

0 · Reply

Zerynx Feb. 6 at 12:43 PM

$GDTC great future ahead for this company. https://www.globenewswire.com/news-release/2025/02/06/3021922/0/en/CytoMed-Therapeutics-announces-Chairman-s-Letter-to-the-Company-s-shareholders.html

0 · Reply

Chevygirl1975 Feb. 5 at 1:43 PM

$TNXP okay. $TNXP looks like toast. Nice 6 month chart for $GDTC though. Just saying. It's not a day trade, it looks steady.

0 · Reply

Zerynx Feb. 4 at 6:14 PM

$GDTC

0 · Reply

Zerynx Jan. 25 at 3:55 PM

$GDTC this will be big once their phase 2 clinical trial yields positive results.

0 · Reply

monkeysun Jan. 20 at 5:29 PM

$FGI $TENX $GDTC $NISN $ABVE

0 · Reply

Brence04 Jan. 17 at 5:52 PM

$GDTC 🔥 $3 soon

0 · Reply

Market Cap	24.62M
Revenue (ttm)	50,000.00
Net Income (ttm)	-1.84M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-3,680.00%
Debt to Equity Ratio	0.06

Volume	40,500
Avg Vol	15,500
Day's Range	N/A - N/A
Shares Out	10.94M
Stochastic %K	30%
Beta	-0.38
Analysts	Strong Buy
Price Target	$5.00